These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17582275)

  • 21. Current strategies in the management of bronchopulmonary dysplasia: the role of corticosteroids.
    Knoppert DC; Mackanjee HR
    Neonatal Netw; 1994 Apr; 13(3):53-60. PubMed ID: 8152411
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ureaplasma infection and neonatal lung disease.
    Schelonka RL; Waites KB
    Semin Perinatol; 2007 Feb; 31(1):2-9. PubMed ID: 17317421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surfactant function and composition in premature infants treated with inhaled nitric oxide.
    Ballard PL; Merrill JD; Truog WE; Godinez RI; Godinez MH; McDevitt TM; Ning Y; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2007 Aug; 120(2):346-53. PubMed ID: 17671061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perinatal prevention of bronchopulmonary dysplasia.
    Greenough A; Ahmed N
    J Perinat Med; 2013 Jan; 41(1):119-26. PubMed ID: 23096098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relation of exhaled nitric oxide levels to development of bronchopulmonary dysplasia.
    May C; Williams O; Milner AD; Peacock J; Rafferty GF; Hannam S; Greenough A
    Arch Dis Child Fetal Neonatal Ed; 2009 May; 94(3):F205-9. PubMed ID: 19383857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postnatal glucocorticoid therapy for prevention of bronchopulmonary dysplasia: routes of administration compared.
    Cole CH
    Semin Neonatol; 2001 Aug; 6(4):343-50. PubMed ID: 11972435
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants.
    Baier RJ; Loggins J; Kruger TE
    BMC Pediatr; 2003 Sep; 3():10. PubMed ID: 12956892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.
    Ballard PL; Truog WE; Merrill JD; Gow A; Posencheg M; Golombek SG; Parton LA; Luan X; Cnaan A; Ballard RA
    Pediatrics; 2008 Mar; 121(3):555-61. PubMed ID: 18310205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Definitions and diagnostic criteria for bronchopulmonary dysplasia.
    Bancalari E; Claure N
    Semin Perinatol; 2006 Aug; 30(4):164-70. PubMed ID: 16860155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of infants with bronchopulmonary dysplasia in North America.
    Bancalari E; Wilson-Costello D; Iben SC
    Early Hum Dev; 2005 Feb; 81(2):171-9. PubMed ID: 15748972
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in bronchopulmonary dysplasia.
    Strueby L; Thébaud B
    Expert Rev Respir Med; 2014 Jun; 8(3):327-38. PubMed ID: 24666156
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased incidence of bronchopulmonary dysplasia after early management changes, including surfactant and nasal continuous positive airway pressure treatment at delivery, lowered oxygen saturation goals, and early amino acid administration: a historical cohort study.
    Geary C; Caskey M; Fonseca R; Malloy M
    Pediatrics; 2008 Jan; 121(1):89-96. PubMed ID: 18166561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lung protective strategies for premature infants].
    Moriette G; Maury L; Le Huidoux P; Jarreau PH
    Arch Pediatr; 2005 May; 12(5):573-8. PubMed ID: 15885550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bronchopulmonary dysplasia in ex-prematures approaching adulthood].
    Vrijlandt EJ; Gerritsen J; Duiverman EJ
    Ned Tijdschr Geneeskd; 2007 Nov; 151(44):2445-51. PubMed ID: 18064864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Research advance in prevention and treatment of bronchopulmonary dysplasia in premature infants].
    Xuan Z; Xue XD; Fu JH
    Zhongguo Dang Dai Er Ke Za Zhi; 2010 May; 12(5):412-6. PubMed ID: 20497659
    [No Abstract]   [Full Text] [Related]  

  • 36. Bronchopulmonary dysplasia: clinical aspects and preventive and therapeutic strategies.
    Principi N; Di Pietro GM; Esposito S
    J Transl Med; 2018 Feb; 16(1):36. PubMed ID: 29463286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland].
    Kwinta P; Grudzień A; Pawlik D; Olechowski W; Lauterbach R; Pietrzyk JJ
    Przegl Lek; 2009; 66(1-2):14-20. PubMed ID: 19485250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
    Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
    Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic evaluation of inhaled nitric oxide in preterm infants undergoing mechanical ventilation.
    Zupancic JA; Hibbs AM; Palermo L; Truog WE; Cnaan A; Black DM; Ballard PL; Wadlinger SR; Ballard RA;
    Pediatrics; 2009 Nov; 124(5):1325-32. PubMed ID: 19841125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a role for antioxidant therapy in bronchopulmonary dysplasia?
    Welty SE
    J Nutr; 2001 Mar; 131(3):947S-950S. PubMed ID: 11238792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.